24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/xyra-announces-the-issuance-of-a-fifth-new-us-patent-in-a-series-of-patents-which-protect-the-use-of-budiodarone-in-the-management-of-atrial-fibrillation-till-after-2040-302436581.html